ATUL SARAN

Profile

First Name

: ATUL

Middle Name

:

Last Name

: SARAN

Related Companies

Titles

Company Name

Related People

DIRECTOR

INOTEK PHARMACEUTICALS CORP

RUDOLF A. BAUMGARTNER, MD, JAMES G. HAM, III, ITTAI HAREL, PAUL G. HOWES, ARGERIS ("JERRY") N. KARABELAS, PHD, JOHN LEAMAN, MAGGIE FLANAGAN LEFLORE, PHD, MICHAEL D. LOBERG, PHD, WILLIAM K. MCVICAR, PH.D., MARTIN VOGELBAUM

DIRECTOR

VENTIRX PHARMACEUTICALS INC.

KATHLEEN FANNING, STEVEN GILLIS, PH.D., ELLIOT GROSSBARD, M.D., PATRICK HERON, ROBERT M. HERSHBERG, M.D., PH.D., MICHAEL J. KAMDAR, RON LAUFER, MAGGIE FLANAGAN LEFLORE, PH.D., KENT SNYDER, NICOLE VITULLO

EXECUTIVE OFFICER

EMERGENT BIOSOLUTIONS INC.

DANIEL J ABDUN-NABI, SUE BAILEY, FUAD EL-HIBRI, ZSOLT HARSANYI, JEROME M HAUER, ADAM R HAVEY, GEORGE J. JOULWAN, ROBERT G KRAMER, RICHARD S. LINDAHL, RONALD B RICHARD, KATHERINE STREI, LOUIS W SULLIVAN, KATHRYN C ZOON

DIRECTOR

M. JOHNSTON ERWIN, STEVE GILLIS, STEVEN GILLIS, THONG LE, JOEL MARCUS, LINDSAY RAYLE, DAVID SCHUBERT, CHRISTOPHER TOOMBS, ASISH XAVIER

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

OTHER

DECLINE TO DISCLOSE

Equity

2023-12-15

D

OTHER

DECLINE TO DISCLOSE

Equity

2023-12-15

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2018-10-15

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2014-09-22

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2010-01-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-06-26

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2010-01-08

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-06-09